Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-11
2011-01-11
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S523000
Reexamination Certificate
active
07867995
ABSTRACT:
A βd-Crystalline form of ivabradine hydrochloride of formula (I):characterised by its powder X-ray diffraction data.Medicinal products containing the same which are useful as bradycardics.
REFERENCES:
patent: 0534859 (1993-03-01), None
Preliminary Search Report for French National Application FR0501987, Aug. 24, 2005.
Ferrari, et al.,European Heart Journal Supplements, 2005, 7 (Supplement H), H16-H21.
Fox,European Heart Journal Supplements, 2005, 7 (Supplement H), H33-H36.
Auguste Marie-Noelle
Damien Gerard
Horvath Stephane
Hueschen and Sage
Kifle Bruck
Les Laboratoires Servier
LandOfFree
βd-crystalline form of ivabradine hydrochloride, a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with βd-crystalline form of ivabradine hydrochloride, a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and βd-crystalline form of ivabradine hydrochloride, a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695148